Sign in to view content

Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

Peter A. Campochiaro, MD

Video
Published 2021

Related

Biodistribution of Suprachoroidal Drug and Viral Vector Delivery Across Animal Models and Human Trials
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2022
The Effect of Intravitreal Afilbercept on Perfusion Status in Patients with Retinal Vascular Disease
Jeffrey S. Heier, MD
Updates from the Field
2016
Pharmacokinetic Profile of the Port Delivery System With Ranibizumab in the Phase 3 Archway Trial
John W. Kitchens, MD
Annual Meeting Talks
2021

Category: Pharmacology

See more